Susan D Scarla, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5656 S Power Rd, Higley, AZ 85236 Phone: 480-840-3733 Fax: 480-969-6132 |
News Archive
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
Today, during the Sapphire Award Presentation, eight honorees were recognized for positively impacting the health of their fellow Floridians. The Sapphire Award is presented annually by Blue Cross and Blue Shield of Florida (BCBSF) Foundation, the philanthropic affiliate of Blue Cross and Blue Shield of Florida.
Giving children under 5 years old an extra dose of inactivated polio vaccine (IPV) helps to boost their immunity to the poliovirus and should be added to vaccination programmes in polio-endemic countries and those facing a high risk of imported cases, suggests new research published in The Lancet.
​Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have developed a method to synthesize modified forms of an established antibiotic called spectinomycin.
› Verified 8 days ago